ITU Unit Action

GREENWORX

GreenLight Biosciences, Inc.

ITU Unit Action

Trademark Snap Shot ITU Unit Action
(Table presents the data on ITU Unit Action)

OVERVIEW

SERIAL NUMBER 88443368 FILING DATE 05/23/2019
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY SPARACINO, MARK V
L.O. ASSIGNED 103

PUB INFORMATION

RUN DATE 03/10/2021
PUB DATE 07/14/2020
STATUS 730-FIRST EXTENSION - GRANTED
STATUS DATE 03/08/2021
LITERAL MARK ELEMENT GREENWORX

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT GREENWORX
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 20-OWNER AT PUBLICATION
NAME GreenLight Biosciences, Inc.
ADDRESS 200 Boston Avenue, Suite 1000
Medford, MA 02155
ENTITY 03-CORPORATION
CITIZENSHIP Delaware

GOODS AND SERVICES

INTERNATIONAL CLASS 001
          DESCRIPTION TEXT chemical reagents and RNA sequences being chemical reagents for agricultural purposes and not medical or veterinary purposes, namely, for crop protection and to improve plant health
INTERNATIONAL CLASS 005
          DESCRIPTION TEXT chemical reagents and RNA sequences being chemical reagents used to repel or destroy pests and vermin; Agricultural products, namely, herbicides, pesticides, fungicides; preparations for destroying vermin; Pharmaceutical products, aquaculture products, and veterinary products for human, aquaculture, and animal health in the nature of vaccines and RNA therapeutics for the treatment of infectious diseases, neurological diseases, metabolic diseases, cardiovascular diseases, respiratory diseases, immune system diseases, and cancer; Antibiotics; Vaccines; Gene therapy products, namely mRNA therapeutics and siRNA therapeutics for medical or clinical use for the treatment of infectious diseases, respiratory diseases, immune system diseases, cardiovascular diseases, and cancer; RNA in the nature of vaccines and therapeutics for scientific, research, medical, pharmaceutical, veterinary, agricultural, aquaculture, chemical and energy production, industrial and manufacturing use for the treatment of infectious diseases, neurological diseases, metabolic diseases, cardiovascular diseases, respiratory diseases, immune system diseases, and cancer
INTERNATIONAL CLASS 030
          DESCRIPTION TEXT Sugar and sugar substitutes

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 001 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 030 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO
PSEUDO MARK GREEN WORK

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
03/10/2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED 025
03/08/2021 EX1G S EXTENSION 1 GRANTED 024
03/08/2021 EXT1 S EXTENSION 1 FILED 023
03/08/2021 EEXT I TEAS EXTENSION RECEIVED 022
09/08/2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT 021
07/14/2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED 020
07/14/2020 PUBO A PUBLISHED FOR OPPOSITION 019
06/24/2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED 018
06/10/2020 ALIE A ASSIGNED TO LIE 017
06/05/2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER 016
06/03/2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 015
06/03/2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 014
06/03/2020 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED 013
12/11/2019 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED 012
12/11/2019 GNFR O FINAL REFUSAL E-MAILED 011
12/11/2019 CNFR R FINAL REFUSAL WRITTEN 010
11/25/2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 009
11/25/2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 008
11/25/2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 007
09/30/2019 DOCK D ASSIGNED TO EXAMINER 006
06/14/2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED 005
06/14/2019 GNRT F NON-FINAL ACTION E-MAILED 004
06/14/2019 CNRT R NON-FINAL ACTION WRITTEN 003
06/07/2019 DOCK D ASSIGNED TO EXAMINER 002
06/07/2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Christina M. Licursi
CORRESPONDENCE ADDRESS Christina M. Licursi
WOLF, GREENFIELD & SACKS, P.C.
600 ATLANTIC AVENUE
BOSTON MA 02210
DOMESTIC REPRESENTATIVE NONE

PRIOR OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME GreenLight Biosciences, Inc.
ADDRESS 200 Boston Avenue, Suite 1000
Medford, MA 02155
ENTITY 03-CORPORATION
CITIZENSHIP Delaware

ITU Unit Action [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed